Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04949893
Other study ID # PRURI SINE (29BRC18.0247)
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2, 2019
Est. completion date October 2, 2019

Study information

Verified date July 2021
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to include all patients followed between 2008 and 2018 in order to analyze the etiologie of the chronic pruritus


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date October 2, 2019
Est. primary completion date October 2, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - more than 18 years old - In patient in a day hospital or longer hospitalization in the dermatology department - With chronic pruritus which means pruritus longer than 6 weeks without skin lesions specific to pruritic dermatitis. Exclusion Criteria: - Itchy dermatose - Refusal to particpate

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHRU de Brest Brest

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Causes of chronic pruritus Analyze the etiology of chronic pruritus : uremic pruritus, cholestatic pruritus, haematologic pruritus, metabolic pruritus, neuropathic pruritus, psychogenic pruritus, idiopathic pruritus thanks to results of biological parameters, Imaging data, clinical data (for example consultation with psychiatric for psychogenic pruritus) through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT05038982 - Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin Phase 2
Completed NCT01951274 - VPD-737 for Treatment of Chronic Pruritus Phase 2
Completed NCT02672579 - Study of Kids Itch Severity (SKIS)
Completed NCT03751111 - Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone Phase 1/Phase 2
Completed NCT04693195 - A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis Phase 2
Not yet recruiting NCT05678309 - Establishment of a Patient Library in Patients With Pruritus Sine Materia